[A sphingolipidosis with the accumulation of neutral glycosphingolipids, AO2(GM3) and A1(GM2)-ganglioside (author's transl)].
D001921:Brain / Q000378:metabolism*; D002518:Ceramides / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D002648:Child; D005227:Fatty Acids / Q000378:metabolism; D005690:Galactose / Q000378:metabolism; D005732:Gangliosides / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D006017:Glycolipids / Q000378:metabolism*; D006601:Hexoses / Q000378:metabolism; D006801:Humans; D008064:Lipidoses / Q000378:metabolism; D010169:Palmitic Acids / Q000378:metabolism; D010296:Parietal Lobe / Q000378:metabolism; D011149:Pons / Q000378:metabolism; D011699:Putamen / Q000378:metabolism; D013106:Sphingolipidoses / Q000378:metabolism* / Q000473:pathology; D013107:Sphingolipids / Q000378:metabolism*; D013229:Stearic Acids / Q000378:metabolism; D013788:Thalamus / Q000378:metabolism
D002518:Ceramides; D005227:Fatty Acids; D005732:Gangliosides; D006017:Glycolipids; D006601:Hexoses; D010169:Palmitic Acids; D013107:Sphingolipids; D013229:Stearic Acids; D005947:Glucose; D005690:Galactose
Uber eine Sphingolipidose mit Anreicherung von neutralen Glykosphingolipiden, AO2(GM3)-und A1(GM2)-gangliosid